[144] Blend Labs, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Blend Labs, Inc. (BLND) reporting a proposed sale of 25,000 common shares through Charles Schwab & Co., Inc. with an approximate aggregate market value of $109,069 and an approximate sale date of 09/15/2025 on the NYSE. The filer shows these 25,000 shares were acquired on 02/17/2020 by exercise and held, with payment in cash. The filing lists prior dispositions by Brian Kneafsey totaling 175,000 shares sold between 06/16/2025 and 08/15/2025 for aggregate gross proceeds of $575,145. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice showing continued sales by an insider and a planned small block sale, with full acquisition disclosure.

The filing documents a proposed 25,000-share sale by a person who acquired the shares via exercise on 02/17/2020 and paid cash. It also discloses recent sales by the same individual totaling 175,000 shares for $575,145 in gross proceeds over roughly two months. From a market-impact perspective, the single proposed sale represents a small fraction of the 255,696,747 shares outstanding, suggesting limited direct pressure on market liquidity, while the cumulative recent sales are clearly disclosed for investor transparency.

Corporate Governance Expert

TL;DR: Form 144 provides compliant disclosure of insider sales and acquisition details; no governance or compliance red flags are evident from the form itself.

The document includes required details: acquisition date and nature (exercise and hold), payment method (cash), broker name, intended sale date, and prior transactions. The filer attests they possess no undisclosed material adverse information. The filing does not present information about any trading plan adoption date under Rule 10b5-1, and no additional governance concerns are stated within the form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	25000	109069.00	255696747	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2020	Exercise and Hold	BLEND LABS, INC.			25000	02/17/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	06/16/2025	45000	145268.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	06/23/2025	20000	63315.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	06/30/2025	20000	66240.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/07/2025	20000	69182.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/14/2025	20000	68438.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/15/2025	25000	90829.00
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	08/15/2025	25000	71873.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for BLND report?

The form reports a proposed sale of 25,000 common shares with an aggregate market value of $109,069, to be sold on 09/15/2025 through Charles Schwab & Co., Inc.

How and when were the 25,000 shares being offered on Form 144 acquired?

The shares were acquired on 02/17/2020 by exercise and held, with payment made in cash.

How many shares did the filer sell in the past three months and for how much?

The filer sold a total of 175,000 shares across seven transactions from 06/16/2025 to 08/15/2025 for aggregate gross proceeds of $575,145.

Which broker is handling the proposed sale listed on Form 144?

The proposed sale is listed with Charles Schwab & Co., Inc. located at 3000 Schwab Way, Westlake, TX 76262.

Does the Form 144 state the filer knows of any undisclosed material adverse information?

The filer represents by signing the notice that they do not know of any material adverse information about the issuer that has not been publicly disclosed.